Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
What would be your post-operative therapy approach for a high grade neuroendocrine carcinoma of the thymus?
What if there was mediastinal nodal involvement?
Answer from: Radiation Oncologist at Academic Institution
Postoperative RT.
Sign In
or
Register
to read more
13071
Related Questions
In resected N2 NSCLC, what nodal pathologic characteristics prompt you to recommend PORT?
How does neoadjuvant chemo-immunotherapy impact your decision on hypofractionation/dose fractionation for locally advanced NSCLC, now getting RT alone?
In ES-SCLC presenting with extensive brain metastases, how do you time whole brain radiation after the first cycle of chemotherapy has already been delivered?
In a patient who underwent cryoablation for early NSCLC, is there a role for giving preemptive further local therapy?
Does receipt of chemoimmunotherapy for LS-SCLC impact your recommendation for PCI?
Do more fractionated regimens reduce severe toxicity over SBRT in patients with ILD and early-stage NSCLC?
How does metaplastic thymoma histology impact your decision regarding adjuvant radiation?
Do you restrict the dose rate during treatment delivery to a pacemaker in addition to limiting the Dmax?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
Is there a role for the addition of radiation to preoperative chemoimmunotherapy in NSCLC with limited N2 disease planned for surgery?